Suppr超能文献

中国广州 2019 年冠状病毒病病例的免疫病理学特征。

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.

机构信息

Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

Immunology. 2020 Jul;160(3):261-268. doi: 10.1111/imm.13223.

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory disorder caused by the highly contagious severe acute respiratory syndrome coronavirus 2. The immunopathological characteristics of patients with COVID-19, either systemic or local, have not been thoroughly studied. In the present study, we analysed both the changes in the number of various immune cell types as well as cytokines important for immune reactions and inflammation. Our data indicate that patients with severe COVID-19 exhibited an overall decline of lymphocytes including CD4 and CD8 T cells, B cells and natural killer cells. The number of immunosuppressive regulatory T cells was moderately increased in patients with mild COVID-19. Interleukin-6 (IL-6), IL-10 and C-reactive protein were remarkably up-regulated in patients with severe COVID-19. In conclusion, our study shows that the comprehensive decrease of lymphocytes, and the elevation of IL-6, IL-10 and C-reactive protein are reliable indicators of severe COVID-19.

摘要

2019 年冠状病毒病(COVID-19)是一种由高传染性的严重急性呼吸系统综合征冠状病毒 2 引起的呼吸系统疾病。COVID-19 患者的全身或局部免疫病理学特征尚未得到彻底研究。在本研究中,我们分析了各种免疫细胞类型的数量变化以及对免疫反应和炎症很重要的细胞因子。我们的数据表明,重症 COVID-19 患者的淋巴细胞(包括 CD4 和 CD8 T 细胞、B 细胞和自然杀伤细胞)数量总体下降。轻度 COVID-19 患者的免疫抑制性调节 T 细胞数量中度增加。重症 COVID-19 患者的白细胞介素 6(IL-6)、白细胞介素 10(IL-10)和 C 反应蛋白显著上调。总之,我们的研究表明,淋巴细胞的全面减少以及 IL-6、IL-10 和 C 反应蛋白的升高是重症 COVID-19 的可靠指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08c0/7341548/f3fa39749634/IMM-160-261-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验